Murray Stewart will become Novelion Therapeutics Inc.'s executive vice president and head of research and development Nov. 27.
Stewart is joining Novelion Therapeutics from GlaxoSmithKline plc, where he serves as the chief medical officer.
GSK exec joins Novelion Therapeutics as EVP/head of R&D
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
GSK exec joins Novelion Therapeutics as EVP/head of R&D
- Author Angelee Tabios
- Theme Healthcare & Pharmaceuticals
- Author
- Angelee Tabios
- Theme
- Healthcare & Pharmaceuticals